A new drug to manage resistant chronic pain
Tel Aviv University develops BL-7050 to ease the neuropathic pain of millions of sufferers.
Tel Aviv University develops BL-7050 to ease the neuropathic pain of millions of sufferers.
Researchers from Galway have published a study that assesses the economic cost of chronic pain in Ireland.
by Dr Alison Louise Jones (pictured) – The headline figures are that the majority of women survive a diagnosis of breast cancer: 78% of those women currently diagnosed… read more.
The difficulties that many women describe as memory problems when menopause approaches are real, according to a study published today in the journal Menopause, the journal of the… read more.
In Europe, osteoporotic fractures account for more Disability Adjusted Life Years (DALYs) lost than common cancers with the exception of lung cancer.
A study of discontinuing natalizumab for multiple sclerosis patients testing positive for JC virus antibody found a higher relapse rate within 6 months than for patients continuing the… read more.
A University of Miami study shows that women with non-metastatic breast cancer who are physically active and receive stress management intervention during treatment may reduce depression and lessen… read more.
by Dr Sunil Upadhyay – Prostate cancer is one of the leading causes of death due to cancer in men all over the world. Most of the prostate… read more.
by Dr Sunil Upadhyay – Despite encouraging progress in the early diagnosis and better management outcome of common cancers, a high proportion of patients still present with advanced… read more.
by Maria Dalby reporting on the presentation by José Ramón Nuñez, Hospital Clinico San Carlos, Madrid, Spain. A nation-wide protocol for retrieving organs after cardiac death outside the… read more.
FDA Highlights – by Bruce Sylvester – Patients who received standard therapy for cystic fibrosis plus adjunctive inhaled dry powder mannitol have achieved sustained improvement in lung function… read more.
FDA Highlights – by Bruce Sylvester – The human papilloma virus (HPV) vaccine can help prevent anal cancer in men, researchers reported in the October 27, 2011, issue… read more.